Reaction
Injection Site Coldness reporting signals
As of the last recalculation, Injection Site Coldness appears in 824 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is TIRZEPATIDE (PRR 74.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tirzepatide | 303 | 74.3 | 74.5 |
| Epinephrine | 61 | 25.3 | 25.4 |
| Dulaglutide | 67 | 20.7 | 20.7 |
| Exenatide | 35 | 17.5 | 17.5 |
| Galcanezumab-Gnlm | 16 | 13.1 | 13.1 |